Our Chief Scientific Officer at the American Cancer Society, Bill Dahut, discusses the annual report that was released today. @goodmorningamerica.bsky.social @acscan.bsky.social www.goodmorningamerica.com/wellness/vid...

American Cancer Society releases annual report

Dr. William Dahut, the chief scientific officer at the American Cancer Society, discusses this year's findings — including that certain cancers are more likely to be seen in women and younger ad...

goodmorningamerica.com

I feel extremely blessed to work at the American Cancer Society. We have seen lots of change during the past year, but importantly, we funded $132 million in new grants that included several new grant mechanisms! I am excited for 2025 and am looking forward to what the new year will bring!!!

Interested in the grants admin side of cancer research? The ACS Clinical and Population Science Program is recruiting a Program Manager. Prefer experience in etiology, prevention, screening/detection, treatment, and/or survivorship. Fully remote position. jobs.cancer.org/job/atlanta/...

Congrats to the @ebos.bsky.social lab! Glad to see high impact publications from studies supported by the American Cancer Society Mission Boost Grant program! www.cancer.org/research/we-...

Mission Boost Grants

The American Cancer Society (ACS) offers a limited number of grants to select current and past ACS grantees specifically for the translation of their research to human testing.

cancer.org

John Ebos@ebos.bsky.social · 2y ago

📣New paper from our lab published in @emboreports.bsky.social 📣 Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors @roswellpark.bsky.social @acscan.bsky.social #Cansky #oncosky #medsky #cancerresearch #drugresistance

Happy to see this mechanistic work from the @rothbartlab.bsky.social lab supported in part from the American Cancer Society!

Scott Rothbart@rothbartlab.bsky.social · 2y ago

Thrilled to share a new study from the lab revealing an H3K18ub-H3K9me3 crosstalk mechanism, roles for UHRF1 and its E3 ligase activity in regulating a hierarchy of repressive histone methylation signaling, and a strategy for targeting SUV39H1/H2 to improve DNMT1 inhibitor efficacy! #epigenetics